HS
Harmanpreet Singh
About Harmanpreet Singh
Data last updated:
Harmanpreet Singh is a Director at Nixi Laboratories Private Limited (since 2016). The companies operate in Pharma, Trading and Professional Services. Nixi Laboratories Private Limited reported revenue of ₹80.22 Cr (FY 2025). Earlier, Harmanpreet Singh was a Director at Transglobal Odyssey Private Limited (2022–2023) and Director at Sunvet Pharma Private Limited (2014–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nixi Laboratories Private Limited U24100HP2016PTC001167 | Director | 08 Mar 2016 | 2016 | ₹80.22 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Transglobal Odyssey Private Limited U46909DL2022PTC392157 | Director | 06 Jan 2022 | 2022 | ₹2.25 Cr (FY 2025) | Active |
 Sunvet Pharma Private Limited U24239HR2002PTC034816 | Director | 13 Jan 2014 | 2002 | ₹21.53 Cr (FY 2024) | Active |
| Nbsb Surgicals Private Limited U74110RJ1996PTC012272 | Director | 26 Feb 2018 | 1996 | ₹5.1 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Harmanpreet Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Gupta | 00694184 | Nixi Laboratories Private Limited | Director |
| Gurudev Singh Raina | 11026160 | Nixi Laboratories Private Limited | Whole-Time Director |
| Paresh Shantilal Bagadia | 01636125 | Nixi Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harmanpreet Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harmanpreet Singh
Harmanpreet Singh currently holds 1 directorship: Nixi Laboratories Private Limited (Director, since 08 Mar 2016, revenue ₹80.22 Cr (FY 2025)).
Harmanpreet Singh was first appointed on 13 Jan 2014 as Director at Sunvet Pharma Private Limited. The most recent appointment on record is 06 Jan 2022 at Transglobal Odyssey Private Limited.
Harmanpreet Singh held 3 earlier board appointments: Transglobal Odyssey Private Limited (Director, 06 Jan 2022 to 01 Dec 2023); Sunvet Pharma Private Limited (Director, 13 Jan 2014 to 20 Aug 2021); Nbsb Surgicals Private Limited (Director, 26 Feb 2018 to 14 Aug 2018).
The current boards of Harmanpreet Singh's companies include Aditya Gupta (Nixi Laboratories Private Limited), Gurudev Singh Raina (Nixi Laboratories Private Limited), Paresh Shantilal Bagadia (Nixi Laboratories Private Limited).